DB International Stock Brokers Ltd

Meeting Details

• Board meeting scheduled for October 21, 2026; time and venue not disclosed.

Key Agenda Items

• Consider unaudited standalone and consolidated financial results for quarter and half-year ended September 30, 2026.
• Consider sale of retail client business to prospective buyer(s); MD authorized to sign MoU/term sheet.

Other Notes

AGM Details

• Date and time: 29 September 2026, 10:30 A.M.
• Mode: Video Conferencing / Other Audio-Visual Means (VC/OAVM).
• Record date: 22-09-2026.
• Total shareholders on record date: 6200.
• Shareholders attending via VC: Promoters 6, Public 77.
• No. of resolutions passed: 2.

Resolutions

• Resolution 1: Adopt standalone and consolidated audited financial statements for year ended 31 March 2026.
• Resolution 2: Re-appoint Shiv Narayan Daga as Managing Director; retires by rotation.

Voting Results

• Resolution 1 passed with 100% in favour; no against.
• Resolution 2 passed with 100% in favour; no against.

MD/Director Appointment

• MD re-appointment: Shiv Narayan Daga; term not specified.

AGM Details

• AGM held September 29, 2026 at 10:30 a.m. IST via VC/OAVM.
• Quorum for AGM was present.
• Meeting concluded at 11:03 a.m. IST.

Ordinary Business

• Adoption of standalone and consolidated financial statements for year ended March 31, 2026.
• Re-appointment of Shiv Narayan Daga as Managing Director, retiring by rotation.

Voting & Outcomes

• Remote e-voting was available from September 26–28, 2026; votes cast at AGM.
• Voting results to be declared on the company website and stock exchanges.
• No other business was transacted.

DB International Stock Brokers Ltd: Trading Window for dealing in the securities of the Company will be closed for all Designated Persons and their Immediate Relatives with effect from October 01, 2026 till the expiry of 48 hours after the declaration of un-audited Standalone and Consolidated Financial Results of the Company for the quarter & half year ended September 30, 2026.

Proposed divestiture

• Approved transfer of major client business to a prospective buyer.
• Authorized Chairman & MD to identify, engage, negotiate terms, and finalize MoU and related documents.
• Subject to shareholders' approval at Extraordinary General Meeting and other regulatory approvals.
• Disclosures to stock exchanges under Listing Regulations will be made when determined.

Meeting Details

• Board meeting scheduled for September 17, 2026; time and venue not disclosed.

Key Agenda Items

• Transfer major client business (trading, DP, mutual funds, other products) to a buyer; terms to be discussed.